Sign in to view content

Regulation of Epithelial-Mesenchymal Transition via RUNX1 in Proliferative Vitreoretinopathy

Leo A. Kim, MD, PhD

Video
Published 2019

Related

Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy Associated with Rhegmatogenous Retinal Detachment: The Phase II FIXER Trial
Ayman Elnahry, MD, PhD
Annual Meeting Talks
2023
ILM Peel, Retinal Hydration, Fibrin Glue, and C3F8 Gas for Recalcitrant Macular Holes
Kamal Kishore, MD, MBBS
Annual Meeting Talks
2021
Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications
Christina Joy Flaxel, MD
Annual Meeting Talks
2023

Category: Retinal Detachment

See more